US Stock MarketDetailed Quotes
RGNX Regenxbio
- 9.590
- +0.410+4.47%
Close Nov 22 16:00 ET
- 9.450
- -0.140-1.46%
Post 18:01 ET
475.14MMarket Cap-1914P/E (TTM)
9.820High9.000Low684.38KVolume9.150Open9.180Pre Close6.54MTurnover1.69%Turnover RatioLossP/E (Static)49.55MShares28.80052wk High1.58P/B389.36MFloat Cap8.53552wk Low--Dividend TTM40.60MShs Float85.100Historical High--Div YieldTTM8.93%Amplitude7.070Historical Low9.554Avg Price1Lot Size
Regenxbio Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -16.31%24.2M | 11.60%22.3M | -18.37%15.62M | -19.94%90.24M | -29.13%22.21M | 9.06%28.91M | -38.81%19.98M | -13.86%19.14M | -76.03%112.72M | -92.14%31.35M |
| Operating revenue | -16.31%24.2M | 11.60%22.3M | -18.37%15.62M | -19.94%90.24M | -29.13%22.21M | 9.06%28.91M | -38.81%19.98M | -13.86%19.14M | -76.03%112.72M | -92.14%31.35M |
| Cost of revenue | -0.01%12.39M | 11.65%10.58M | 4.16%4.28M | -31.78%37.21M | -12.09%11.24M | -5.39%12.39M | -26.84%9.48M | -73.84%4.11M | 5.23%54.55M | -44.56%12.78M |
| Gross profit | -28.54%11.81M | 11.56%11.72M | -24.54%11.34M | -8.85%53.03M | -40.87%10.98M | 23.16%16.53M | -46.68%10.5M | 131.13%15.03M | -86.10%58.18M | -95.06%18.56M |
| Operating expense | -9.32%73.89M | -18.97%67.75M | -9.96%73.1M | 0.03%321.16M | -1.91%74.88M | -3.52%81.49M | 1.68%83.61M | 4.04%81.18M | 24.18%321.06M | 23.12%76.33M |
| Selling and administrative expenses | -15.86%19.42M | -20.44%18.86M | -19.19%18.29M | 3.77%88.49M | -10.05%19.08M | 10.33%23.08M | 13.76%23.7M | 1.42%22.63M | 7.50%85.28M | -3.77%21.21M |
| -General and administrative expense | -15.86%19.42M | -20.44%18.86M | -19.19%18.29M | 3.77%88.49M | -10.05%19.08M | 10.33%23.08M | 13.76%23.7M | 1.42%22.63M | 7.50%85.28M | -3.77%21.21M |
| Research and development costs | -6.45%54.43M | -18.40%48.87M | -6.28%54.84M | -4.20%232.27M | -10.92%55.68M | -8.10%58.18M | -1.84%59.89M | 5.19%58.52M | 33.63%242.45M | 30.28%62.51M |
| Provision for doubtful accounts | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
| Other operating expenses | -83.18%37K | 11.54%29K | -203.03%-34K | 105.94%397K | 101.60%118K | -3.93%220K | -93.35%26K | -60.24%33K | -2,105.71%-6.68M | ---7.38M |
| Operating profit | 4.44%-62.08M | 23.35%-56.04M | 6.64%-61.76M | -2.00%-268.13M | -10.61%-63.9M | 8.56%-64.96M | -16.91%-73.11M | 7.51%-66.16M | -264.32%-262.88M | -118.42%-57.77M |
| Net non-operating interest income expense | 49.30%-795K | 61.11%-420K | 27.90%-1.94M | 70.16%-6.84M | 64.47%-1.5M | 73.58%-1.57M | 83.90%-1.08M | 55.52%-2.69M | 10.35%-22.91M | 34.69%-4.23M |
| Non-operating interest income | -55.36%25K | -27.50%29K | -47.14%37K | -92.69%25K | -283.12%-141K | 211.11%56K | -73.86%40K | -25.53%70K | -52.43%342K | 305.26%77K |
| Non-operating interest expense | -49.51%820K | -59.91%449K | -28.38%1.97M | -70.49%6.86M | -68.38%1.36M | -72.72%1.62M | -83.67%1.12M | -55.06%2.76M | -11.50%23.25M | -33.69%4.31M |
| Other net income (expense) | -29.70%3.28M | 63.05%3.47M | -83.01%368K | 110.27%11.32M | 16.78%2.37M | 211.29%4.66M | 100.47%2.13M | 171.09%2.17M | -21.13%5.38M | 551.45%2.03M |
| Gain on sale of security | -29.70%3.28M | 63.05%3.47M | 13.99%2.47M | 110.27%11.32M | 16.78%2.37M | 211.29%4.66M | 100.47%2.13M | 171.09%2.17M | -21.13%5.38M | 551.45%2.03M |
| Special income (charges) | --0 | --0 | ---2.1M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| -Less:Impairment of capital assets | --0 | --0 | --2.1M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Income before tax | 3.67%-59.6M | 26.47%-52.99M | 5.02%-63.33M | 5.98%-263.65M | -5.11%-63.04M | 18.04%-61.87M | -5.69%-72.06M | 13.14%-66.68M | -298.52%-280.41M | -119.51%-59.98M |
| Income tax | -80.95%-152K | -100.63%-84K | -100.32%-43K | |||||||
| Net income | 3.67%-59.6M | 26.47%-52.99M | 5.02%-63.33M | 6.00%-263.49M | -4.93%-62.89M | 18.04%-61.87M | -5.69%-72.06M | 13.10%-66.68M | -319.27%-280.32M | -120.38%-59.94M |
| Net income continuous Operations | 3.67%-59.6M | 26.47%-52.99M | 5.02%-63.33M | 6.00%-263.49M | -4.93%-62.89M | 18.04%-61.87M | -5.69%-72.06M | 13.10%-66.68M | -319.27%-280.32M | -120.38%-59.94M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 3.67%-59.6M | 26.47%-52.99M | 5.02%-63.33M | 6.00%-263.49M | -4.93%-62.89M | 18.04%-61.87M | -5.69%-72.06M | 13.10%-66.68M | -319.27%-280.32M | -120.38%-59.94M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 3.67%-59.6M | 26.47%-52.99M | 5.02%-63.33M | 6.00%-263.49M | -4.93%-62.89M | 18.04%-61.87M | -5.69%-72.06M | 13.10%-66.68M | -319.27%-280.32M | -120.38%-59.94M |
| Basic earnings per share | 17.02%-1.17 | 36.75%-1.05 | 9.80%-1.38 | 7.38%-6.02 | -2.90%-1.42 | 19.43%-1.41 | -5.06%-1.66 | 14.53%-1.53 | -315.95%-6.5 | -120.09%-1.38 |
| Diluted earnings per share | 17.02%-1.17 | 36.75%-1.05 | 9.80%-1.38 | 7.38%-6.02 | -2.90%-1.42 | 19.43%-1.41 | -5.06%-1.66 | 14.53%-1.53 | -323.37%-6.5 | -120.69%-1.38 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data